T/SSFSIDC 018-2024 Active
T/SSFSIDC 018-2024 Innovative Financial Support for the Transfer of High-Value Biopharmaceutical Patents Translation Service Guideline
Abstract
Main technical content: 4 Workflows 4.1 Registration 4.2 Certification of Biomedical "Frontier Scientist Teams" 4.3 Project Screening 4.4 Patent Evaluation 4.5 Service Matching 4.6 Project Review 4.7 Loan Approval 5 Credit Enhancement Factors 5.1 Credit Enhancement Based on Expected Patent Revenue 5.2 Credit Enhancement Based on Patent Risk Pool 5.3 Credit Enhancement Based on Biomedical "Frontier Scientist Teams" 5.4 Credit Enhancement Based on Commercial Guarantee Companies 5.5 Credit Enhancement Based on Policy-Based Guarantee Companies 5.6 Credit Enhancement Based on Industrial Policy Awards 5.7 Credit Enhancement Based on High-Value Patents
General Product Information
| Document Type | Group standards |
|---|---|
| Standard Status | Active |
| Standard Code | T/SSFSIDC 018-2024 |
| ICS | Financial services, banking, monetary systems, and insurance |
| Implement Date | 2024-04-19 |